Testimony provided in late March by a urologist in an Actos trial taking place in a Los Angeles court presented an expert’s opinion about the link between Actos and bladder cancer. A urologist, Dr. Norm D. Smith, testified in Cooper v. Takeda Pharmaceuticals America Inc., a case being heard in a California Superior Court.
According to Dr. Smith, after examining all of the plaintiff’s health factors, it appeared to him that the cause of the plaintiff’s bladder cancer had a more significant connection to a prolonged use of Actos.
The plaintiff in the Actos case, Jack Cooper, took the diabetes drug Actos for five years, and discovered in December 2011 that he had bladder cancer. According to Law360, Cooper filed his Actos bladder cancer lawsuit alleging that Takeda, the Japanese pharmaceutical company responsible for the development and marketing of the drug Actos, neglected to inform healthcare providers about the health complications associated with Actos.
The U.S. Food and Drug Administration (FDA) has been reviewing data collected in a collaborative study conducted by Takeda and Kaiser Permanente Northern California. Their data show that patients who ingest high dosages of Actos for a long period of time, usually more than one year, have a significantly increased risk of developing bladder cancer.
Carey Danis & Lowe Actos bladder cancer lawyers are encouraged by Dr. Smith’s testimony, as it supplies the court and the jury with strong evidence from an expert that, despite the plaintiff’s other health problems and lifestyle choices, the primary reason for the development of his bladder cancer lies in the use of Actos for a long period of time.
Carey Danis & Lowe urges individuals who have been injured by Actos to contact one of our Actos bladder cancer lawyers today for a free legal evaluation about your Actos case, and for assistance in filing an Actos bladder cancer lawsuit.
Contact Carey Danis & Lowe by calling 800.721.2519 or by submitting a legal claim form.References: Actos, Pharmaceutical litigation